Tony's Diary Package — page 953

% Viral Lineages Among Infections 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% li: 4/9/22 4/16/22 4/23/22 4/30/22 §/7/22 Collection date, week ending 5/14/22 §/21/22 §/28/22 6/4/22 6/11/22 > USA WHO label Lineage# USClass %Total 95%PI Omicron BA.2.12.1 VOC 64.2% 59.9-68.3% = ne BA.2 VOC 14.2% 12.7-15.9% I I BAS VOC 13.3% 10.0-17.4% BA4 VOC 8.3% 6.3-10.7% BA.1.1 VOC 0.0% 0.0-0.0% B.1.1.529 voc 0.0% 0.0-0.0% Delta B.1.617.2 VBM 0.0% 0.0-0.0% Other Other* 0.0% 0.0-0.1% * Enumerated lineages are US VOC and lineages circulating above 1% nationally in at least one week period. "Other" rep its the aggregation of lineages which are circulating <1% nationally during all weeks displayed. ** These data include Nowcast estimates, which are modeled projections that may differ from weighted estimates generated at later dates # =AY.1-AY.133 and their sublineages are aggregated with B.1.617.2. BA.1, BA.3 and their sublineages (except BA.1.1 and its sublineages) are aggregated with B.1.1.529. For regional data, BA.1.1 and its sublineages are also aggregated with B.1,1.529, as they currently cannot be reliably called in each region. Except BA.2.12.1 and its sublineages, BA.2 sublineages are aggregated with BA.2. BA.5.1 is aggregated with BA.5. I had another very productive discussion, which I have had on a regular basis, with the UK chief medical officer Chris Whitty. We discussed the evolving situation in the UK and compared it to that in the United States. He mentioned to me that they were starting to see a surge of cases of BA5 which he feels will ultimately become dominant. In addition, unfortunately hospitalizations are starting to tick up and he believes that they are likely going to see a bit more of a wave in the coming weeks. This is very disconcerting since we were hoping that there would be a sharp downturn in omicron sublineage viruses in the UK which usually foreshadows what is going to happen in the United states. Egregious example of "PORK" on the part of the Senate Appropriations Subcommittee concerning the earmarking of funding for the BSLs